Yuyu Pharma (000220) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma (000220) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Yuyu Pharma worth for the company's overall valuation and market capitalisation.

Yuyu Pharma - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yuyu Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yuyu Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma ranked by their cash flow conversion efficiency. Explore 000220 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Dogusan Boru Sanayi ve Ticaret AS IS:DOGUB	-0.014x
Verbrec Ltd AU:VBC	0.112x
Lohakit Metal Public Company Limited BK:LHK	0.043x
Imas Makina Sanayi AS IS:IMASM	0.046x
Biokarpet S.A. AT:BIOKA	0.168x
Iodm Ltd AU:IOD	1.084x
Koan Hao Technology Co Ltd TWO:8354	0.021x
HAV GROUP ASA F:6HH	1.028x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma from 2011 to 2024. View 000220 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	+277.82%
2013-12-31	₩72.28 Billion ≈ $48.98 Million	₩-775.17 Million ≈ $-525.32K	-0.011x	-111.45%
2012-12-31	₩69.50 Billion ≈ $47.10 Million	₩6.51 Billion ≈ $4.41 Million	0.094x	-5.64%
2011-12-31	₩67.23 Billion ≈ $45.56 Million	₩6.67 Billion ≈ $4.52 Million	0.099x	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.22 Million

₩62.30 Billion KRW

Market Cap Rank

#22630 Global

#1463 in Korea

Share Price

₩3850.00

Change (1 day)

+0.79%

52-Week Range

₩3435.00 - ₩4740.00

All Time High

₩16106.03